HYBRID EVENT: You can participate in person at London or Virtually from your home or work.
Karen S Fernandez, Speaker at Neonatology Conferences
University of California San Francisco (UCSF), United States

Abstract:

Solid tumors discovered at birth or during the first month after delivery are rare. Neonatal tumors are often benign. Malignant tumors in neonates represent only 2% of all malignancies in childhood. Some tumors that appear histologically malignant may show benign behavior, whereas apparently benign tumors may be fatal by virtue of their site of origin, which makes neonatal tumors one of the most difficult diagnostic and therapeutic challenges in the neonatal units. Planning the diagnostic evaluation and therapeutic interventions necessitates a multidisciplinary approach that involves the neonatology, radiology, surgery, pathology, hematology, and oncology services. Here we provide a general overview of the most common tumors seen in the newborn period and address some of the initial approach to their treatment.

Biography:

Karen S. Fernandez is a Pediatric oncologist with expertise in solid tumors and Hodgkin lymphoma. She currently serves as the director of the solid tumor program at Valley Children’s Hospital in Madera, California and has an academic affiliation with the University of California San Francisco. In addition to practicing pediatric oncology. Fernandez is involved in hematology/oncology global health initiatives, and has participated in educational and research projects in Guatemala, Vietnam and Uganda.

Watsapp